Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/6/19 → 3/22/22 |
Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (# 60 years) with Relap
- Hildebrandt, Gerhard (PI)